-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A2yauX8/uUr558UsAAF1p32AQ8+RKxcIIyqTW6w7eMar2MecxK1eaAJrf4XCfTax ftG7Kc2ezqY5bziRs28a6A== 0001179110-05-017780.txt : 20050909 0001179110-05-017780.hdr.sgml : 20050909 20050909174502 ACCESSION NUMBER: 0001179110-05-017780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050908 FILED AS OF DATE: 20050909 DATE AS OF CHANGE: 20050909 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOYCE R TODD CENTRAL INDEX KEY: 0001242066 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 051078621 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS, INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 4 1 edgar.xml FORM 4 - X0202 4 2005-09-08 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001242066 JOYCE R TODD C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE CORONA CA 92880 0 1 0 0 VP, Corp. Controller & Treas. Common Stock, par value $0.0033 2005-09-08 4 M 0 9244 19.50 A 10244 D Common Stock, par value $0.0033 2005-09-08 4 S 0 4100 34.75 D 6144 D Common Stock, par value $0.0033 2005-09-08 4 S 0 5144 34.85 D 1000 D Common Stock, par value $0.0033 6207 I Trust Non-Qualified Options to Purchase Common Stock 19.50 2005-09-08 4 M 0 9244 0 D 2002-06-09 2007-06-09 Common Stock, par value $0.0033 9244 0 D This represents shares of restricted stock issued pursuant to the Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. /s/R. TODD JOYCE 2005-09-09 -----END PRIVACY-ENHANCED MESSAGE-----